<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-7">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Aptos;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
font-size:12.0pt;
font-family:"Times New Roman",serif;}
span.EmailStyle17
{mso-style-type:personal-compose;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#0563C1" vlink="#954F72" style="word-wrap:break-word">
<div class="WordSection1">
<div align="center">
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" width="640" style="width:480.2pt;border-collapse:collapse">
<tbody>
<tr style="height:1211.1pt">
<td width="640" style="width:480.2pt;padding:0in 0in 0in 0in;height:1211.1pt">
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" align="left" width="640" style="width:480.2pt;border-collapse:collapse;margin-left:6.75pt;margin-right:6.75pt">
<tbody>
<tr style="height:312.6pt">
<td width="640" style="width:480.2pt;padding:30.0pt 15.0pt 7.5pt 15.0pt;height:312.6pt">
<p class="MsoNormal" align="center" style="text-align:center;line-height:200%"><b><span style="font-family:"Aptos",sans-serif;color:black"><img width="600" height="171" style="width:6.25in;height:1.7812in" id="_x0000_i1087" src="https://www.egr.uh.edu/sites/www.egr.uh.edu/files/enews/2022/images/dissertation1.png" alt="Dissertation Defense Announcement at the Cullen College of Engineering">Multi-functional Optical
Coherence Tomography <o:p></o:p></span></b></p>
<p class="MsoNormal" align="center" style="text-align:center;line-height:200%"><b><span style="font-family:"Aptos",sans-serif;color:black">Assesses Skin Involvement in Systemic Sclerosis</span></b><span style="font-family:"Aptos",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal" align="center" style="text-align:center;line-height:15.0pt">
<b><span style="font-family:"Aptos",sans-serif;color:black">Harshdeep Singh Chawla</span></b><span style="font-family:"Aptos",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal" align="center" style="text-align:center;line-height:15.0pt">
<span style="font-family:"Aptos",sans-serif;color:black">April 21, 2025; 2 p.m. to 5 p.m. (CST)<br>
Location: Room 350 Health 1<o:p></o:p></span></p>
<p class="MsoNormal" align="center" style="text-align:center;line-height:15.0pt">
<b><span style="font-family:"Aptos",sans-serif;color:black"><o:p> </o:p></span></b></p>
<p class="MsoNormal" align="center" style="text-align:center;line-height:15.0pt">
<b><span style="font-family:"Aptos",sans-serif;color:black">Committee Chair:</span></b><span style="font-family:"Aptos",sans-serif;color:black"><br>
Kirill V. Larin, Ph.D.<o:p></o:p></span></p>
<p class="MsoNormal" align="center" style="text-align:center;line-height:15.0pt">
<b><span style="font-family:"Aptos",sans-serif;color:black"><o:p> </o:p></span></b></p>
<p class="MsoNormal" align="center" style="text-align:center;line-height:15.0pt">
<b><span style="font-family:"Aptos",sans-serif;color:black">Committee Members:</span></b><span style="font-family:"Aptos",sans-serif;color:black"><br>
Shervin Assassi, MD, MS | Chandra Mohan, Ph.D. | Jerome Schultz, Ph.D. | David Mayerich, Ph.D.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height:706.5pt">
<td width="640" style="width:480.2pt;padding:7.5pt 15.0pt 15.0pt 15.0pt;height:706.5pt">
<p class="MsoNormal"><b><span style="font-family:"Aptos",sans-serif;color:black">Abstract</span></b><span style="font-family:"Aptos",sans-serif;color:black"><o:p></o:p></span></p>
<p class="MsoNormal" style="text-align:justify"><span style="font-family:"Aptos",sans-serif;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-align:justify"><span style="font-family:"Aptos",sans-serif;color:black">Systemic sclerosis (SSc), or scleroderma, is a chronic autoimmune disorder characterized by fibrosis of skin and internal organs. Early diagnosis and classification
are critical for evaluating disease progression. Although considered rare, the five-year survival rate post-diagnosis is 77.9%, which decreases to 55.5% after ten years, with a median survival of approximately 11 years.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align:justify"><span style="font-family:"Aptos",sans-serif;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-align:justify"><span style="font-family:"Aptos",sans-serif;color:black">Diagnosis of SSc involves clinical evaluations, laboratory tests, and imaging techniques. The 2013 ACR/EULAR criteria offer a standardized method for evaluating
skin thickening, fibrosis lesions, telangiectasias, nailfold capillary abnormalities, pulmonary involvement, Raynaud’s phenomenon, and SSc-specific autoantibodies. One major pathological outcome of SSc is skin involvement, where significant fibrosis in the
skin leads to thickening of the dermis, obliteration of skin appendages like hair follicles and sweat glands, atrophy of the epidermis, and vascular rarefaction, ultimately resulting in tissue hypoxia and impaired skin function.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align:justify"><span style="font-family:"Aptos",sans-serif;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-align:justify"><span style="font-family:"Aptos",sans-serif;color:black">To this end, the modified Rodnan skin score (mRSS) is the standard for measuring the severity of skin involvement in SSc. This assessment uses manual palpation
over 17 body regions, with scores ranging from 0 (normal) to 3 (severely affected), resulting in an overall skin score. However, mRSS is subject to inter-observer variability and can be influenced by factors like skin elasticity, particularly in early SSc
stages. Therefore, establishing an objective tool for skin involvement assessment in SSc is essential for improving prognostic accuracy, monitoring disease progression, evaluating treatment effectiveness, and facilitating the development of effective therapies.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align:justify"><span style="font-family:"Aptos",sans-serif;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-align:justify"><span style="font-family:"Aptos",sans-serif;color:black">Optical coherence tomography (OCT) is a noninvasive, label-free imaging modality that can examine morphological, biomechanical, and vascular changes in
the skin of SSc patients. It has an optimal depth (1-2 mm) and resolution (5-15 ìm) for characterizing skin fibrosis. OCT quantitatively measures tissue parameters, making it ideal for detecting SSc-related changes in skin. OCT performs morphological imaging,
but mechanical assessment of skin can be performed with its elastographic functional extension, optical coherence elastography (OCE), while OCT angiography (OCTA) maps microvasculature affected by SSc.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align:justify"><span style="font-family:"Aptos",sans-serif;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-align:justify"><span style="font-family:"Aptos",sans-serif;color:black">This dissertation discusses the use of multifunctional OCT (i.e., OCT, OCE, and OCTA) to assess skin involvement in a diverse cohort of SSc patients and
matched healthy controls. A multifunctional OCT system was built, and its reliability and operational performance were tested in a murine model of SSc-like fibrosis. The study's results confirmed that multifunctional OCT could detect alterations in murine
skin's mechanical properties, morphology, and vascular characteristics. The system was then converted to a clinic-friendly mobile format for SSc patient imaging at UTHealth. Data was collected from 55 patients and 20 healthy controls, and the results show
strong discrimination of the SSc patients from the healthy subjects but a low-to-moderate correlation with histopathology and qPCR measurements.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-align:justify"><span style="font-family:"Aptos",sans-serif;color:black"><img width="600" height="82" style="width:6.25in;height:.8541in" id="_x0000_i1091" src="https://www.egr.uh.edu/sites/www.egr.uh.edu/files/enews/2022/images/dissertation2.png" alt="Engineered For What's Next"><o:p></o:p></span></p>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr style="height:65.25pt">
<td width="640" style="width:480.2pt;padding:0in 0in 0in 0in;height:65.25pt"></td>
</tr>
</tbody>
</table>
</div>
<p class="MsoNormal"><span style="font-family:"Aptos",sans-serif;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Aptos",sans-serif;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Aptos",sans-serif;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-family:"Aptos",sans-serif;color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri",sans-serif"><o:p> </o:p></span></p>
</div>
</body>
</html>